Harvard Bioscience (HBIO) Tops Q2 EPS by 24c ; Offers Guidance
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $7.96 -0.25%
EPS Growth %: -800.0%
Financial Fact:
Revenues: 25.01M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -800.0%
Financial Fact:
Revenues: 25.01M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q2 EPS of ($0.14), $0.24 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $22.73 million versus the consensus estimate of $21.9 million.
Q3 2026 Outlook:-
Revenue between $21.0 million and $22.6 million vs consensus $21.85 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing wins $20B U.S. Navy contract for sixth-generation fighter jet
- Alaska and American Airlines plan to join Atlantic and Pacific joint businesses
- Trump To Unveil $54 Billion Alaska Lng Plan Amid Midterm Woes - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
